Minitab, LLC, a global leader in data collection, predictive analytics, and process improvement solutions for manufacturers and organizations worldwide, today announced the acquisition of the Effex ...
The primary analysis of this trial showed that first-line treatment with osimertinib plus chemotherapy with a platinum-based agent and pemetrexed led to significantly longer progression-free survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results